Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04041583 · ClinicalTrials.gov registry record
Clinical and Radiological Outcomes of Posterior Cervical Fusion Supplemented With Interfacet Spacers
A clinical trial of Cervical Fusion, sponsored by Ohio State University.
- Recruiting
- Registry status
- 45
- Enrollment target
- 1
- Study location
NCT04041583: Recruiting study of Cervical Fusion, sponsored by Ohio State University.
NCT04041583 is a study of Cervical Fusion that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 45 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04041583, a study of Cervical Fusion, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective study to assess fusion rates and cervical sagittal parameters following posterior cervical arthrodesis procedures supplemented with CIS. Data will be collected from medical records for up to 730 days after surgery. Data to be collected will be demographic, preoperative clinical information, surgical details, and radiographic information. Patients will also undergo a non-standard of care CT scan 2 years after surgery.
Primary Outcome
Cervical Fusion Measured on Post-Operative Radiographs and CT scans
Conditions Studied
Interventions
- DEVICE Cervical Interfacet Spacers
Study Locations (1)
Ohio
- The Ohio State University Wexner Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2026-08 |
What NCT04041583 shows while recruiting
NCT04041583 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.
The record links to 1 condition, with Cervical Fusion appearing as the primary indexed condition, and to 1 intervention - of which Cervical Interfacet Spacers is the first listed.
NCT04041583 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04041583 about?
NCT04041583 is a clinical study titled "Clinical and Radiological Outcomes of Posterior Cervical Fusion Supplemented With Interfacet Spacers". This is a prospective study to assess fusion rates and cervical sagittal parameters following posterior cervical arthrodesis procedures supplemented with CIS. Data will be collected from medical records for up to 730 days after surgery. Data to be collected will be demographic, preoperative clinical...
What is the current status of trial NCT04041583?
This trial is currently recruiting. The enrollment target is 45 participants. The study started on 2019-09-01. Estimated completion is 2026-08.
What conditions does trial NCT04041583 study?
This clinical trial studies the following conditions: Cervical Fusion.
What interventions are being tested in trial NCT04041583?
The interventions under investigation include: Cervical Interfacet Spacers (DEVICE).
Who is sponsoring clinical trial NCT04041583?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04041583 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Fusion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI